SML3602
Pipobroman
≥98% (HPLC)
别名:
1,1′-(1,4-Piperazinediyl)bis[3-bromo-1-propanone, 1,4-bis(3-Bromo-1-oxopropyl)-piperazine, N,N-Bis-(3-bromopropionyl)-piperazine, NSC-25154
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C10H16Br2N2O2
化学文摘社编号:
分子量:
356.05
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
产品名称
Pipobroman, ≥98% (HPLC)
SMILES string
BrCCC(=O)N1CCN(CC1)C(=O)CCBr
InChI
1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2
InChI key
NJBFOOCLYDNZJN-UHFFFAOYSA-N
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Quality Level
Biochem/physiol Actions
Anti-cancer drug, cytostatic alkylating agent
Pipobroman is an alkylating agent that is used as anti-cancer drug. It also has clinical activity in polycythemia vera and thrombocythemia.
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Giovanni Fazio et al.
Journal of thrombosis and thrombolysis, 35(2), 282-285 (2012-07-31)
Polycythemia vera (PV) is a chronic myeloproliferative disorder characterized by an abnormal increase in red blood cells. The involvement of the heart during the course of the illness represents a common cause of morbidity and it is linked to an
Jean-Jacques Kiladjian et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29(29), 3907-3913 (2011-09-14)
The overall impact of hydroxyurea (HU) or pipobroman treatments on the long-term outcome of patients with polycythemia vera (PV) has not been assessed in randomized studies. We report final analyses from the French Polycythemia Study Group (FPSG) study, which randomly
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持